stockrowNeuraxis, Inc. (NRXS) vs Rani Therapeutics Holdings, Inc. (RANI)
- Neuraxis, Inc. NRXS 6.31 +3.27%
- Rani Therapeutics Holdings, Inc. RANI 0.54 +3.85%
Neuraxis, Inc. and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. Neuraxis, Inc. and Rani Therapeutics Holdings, Inc. are of similar size ($76.7M and $72.0M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against 65.2%. Neuraxis, Inc. has the higher net margin (−159.0% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Neuraxis, Inc. leads on 8 and Rani Therapeutics Holdings, Inc. on 7.
Valuation
Profitability
| Metric | NRXS | RANI | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.56% | 100.00% | 68.51% |
| Operating margin | (144.51%) | (652.78%) | 0.00% |
| Net margin | (159.01%) | (596.97%) | 0.00% |
| Free cash flow margin | (106.10%) | (402.83%) | 0.00% |
| Return on equity | (153.96%) | (155.24%) | (51.96%) |
| Return on assets | (98.96%) | (77.54%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack